Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

Pfizer

Status and phase: Completed; Phase 4

Conditions: Osteoarthritis, Hip

Treatments: Drug: Celecoxib; Drug: Diclofenac

Study type: Interventional

Funder types: Industry

Identifiers

NCT00174317

COXA-0508-261

Details and patient eligibility

About

To determine if celecoxib 200 mg once daily is as effective as diclofenac 50 mg three times daily in the treatment of pain symptoms associated with osteoarthritis of the hip

Sex: All

Ages: 45+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with osteoarthritis of hip and requiring joint replacement
• Eligible for chronic therapy with an NSAID

Exclusion criteria

• Hip surgery anticipated within 8 calendar weeks after first visit
• Active gastrointestinal disease or recent diagnosis of gastrointestinal ulceration (within 60 days of first visit)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind